• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Zoetis Establishes Douglasville, Georgia, Operations

Zoetis, a leading animal health company, plans to locate a new manufacturing facility in Douglasville, Georgia. The $100 million project is expected to create 150 jobs.

The company will make improvements to an existing facility which will support and expand capacity of its growing monoclonal antibody and vaccine portfolios. Operations are scheduled for 2026.

“We are excited to expand our manufacturing footprint as the new facility marks a major milestone for our company,” said Nick Ashton, Executive Vice President at Zoetis and President of Global Manufacturing and Supply. “The Douglasville facility provides us with the opportunity to expand production and supply capacity while benefiting the local economy by adding new jobs. We are looking forward to this new space as we strive to serve veterinarians, livestock producers, pet owners and the animals in their care.”

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.

“Elevate Douglas is committed to attracting new investment and quality jobs to our community. Zoetis choosing our community for their new southeast facility is a testament to our commitment and opens new avenues of recruiting additional life science and health technology companies” states Chris Pumphrey, President of Elevate Douglas Economic Partnership. “Life sciences is a growing industry sector and one that offers above average wages across all skill sets, we are excited to work with them to ensure their new facility is successful in Douglasville.”

Exclusive Research